Tag Archive for: investment capital

SMITM CAPITAL MARKETS LTD. has announced a significant agreement with Mid-Atlantic BioTherapeutics, Inc., entailing a capital commitment of $5 million to fuel MABT’s groundbreaking efforts to combat rabies.

The company’s new integrated solution helps emerging biotech companies ‘nail the narrative’ when it comes to securing investment capital, talent and clinical trial participants.